Mineralys Therapeutics In... (MLYS)

NASDAQ: MLYS · Real-Time Price · USD

14.95

0.74 (5.21%)

At close: May 01, 2025, 3:59 PM

14.31

-4.25%

Pre-market: May 02, 2025, 06:53 AM EDT

Mineralys Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Net Income	-177.81M	-153.25M	-119.67M	-90.8M	-71.9M	-56.58M	-40.5M	-34.84M	-29.8M	-27.81M	-21.13M	-14.65M	-7.08M
Depreciation & Amortization	43K	28K	17K	8K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	11.34M	9.66M	5.23M	6.5M	5.06M	3.82M	2.44M	1.19M	455K	253K	61K	35K	16K
Other Working Capital	-20.01M	-4.19M	23.46M	5.27M	-7.47M	-4.41M	-8.78M	-261K	-199.89K	721.26K	984.26K	265.00	157.00
Other Non-Cash Items	22.03M	21.3M	-4.31M	-6.31M	-6.87M	-5.21M	-3.49M	-1.5M	-647.1K	-235.08K	3.92K	2.88K	2.02K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-19.71M	-3.98M	23.64M	5.27M	-7.47M	-4.41M	-8.78M	-261K	772K	3.87M	4.13M	3.15M	2.18M
Operating Cash Flow	-166.31M	-128.45M	-97.3M	-87.54M	-81.17M	-62.38M	-50.34M	-35.42M	-29.22M	-23.93M	-16.94M	-11.47M	-4.89M
Capital Expenditures	-96K	-96K	-59K	-59K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-373.44M	-382.6M	-379.74M	-308.61M	-347.97M	-274.88M	-290.65M	-234.51M	-71.76M	-71.76M	n/a	n/a	n/a
Sales Maturities Of Investments	488.5M	406M	327.5M	232.5M	187.5M	172.5M	112.5M	72.5M	50M	n/a	n/a	n/a	n/a
Other Investing Acitivies	-55.89K	-63.98K	-59.98K	-76.11K	-20.22K	49.99M	49.91M	49.93M	49.93M	-71.76K	n/a	n/a	n/a
Investing Cash Flow	114.96M	23.3M	-52.3M	-76.17M	-160.47M	-102.38M	-178.15M	-162.01M	-21.76M	-71.76M	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	138K	202.58K	64.58K	64.58K	64.58K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	83K	67K	252K	344K	258K	-884K	-1.07M	-1.07M	-1.07M	n/a	n/a	n/a	n/a
Financial Cash Flow	116.14M	116.13M	116.31M	115.88M	203.25M	202.11M	201.36M	319.59M	128.02M	129.09M	129.65M	12M	n/a
Net Cash Flow	64.79M	10.97M	-33.28M	-47.83M	-38.4M	37.34M	-27.12M	122.17M	77.04M	33.4M	112.71M	529K	-4.89M
Free Cash Flow	-166.41M	-128.55M	-97.36M	-87.6M	-81.17M	-62.38M	-50.34M	-35.42M	-29.22M	-23.93M	-16.94M	-11.47M	-4.89M